Oct. 23 at 5:17 PM
$OPK — Undervalued healthcare play with catalysts lining up? 💊
OPKO Health’s RAYALDEE momentum, strategic partnerships, and advancing trials are fueling optimism — even as competition and dependency risks linger.
Full investment case here 👉 https://www.zacks.com/stock/news/2775723/heres-why-you-should-add-opko-health-stock-to-your-portfolio?cid=sm-stocktwits-2-2775723-teaser-17355&ADID=SYND_STOCKTWITS_TWEET_2_2775723_TEASER_17355